Nanjing Vazyme Biotech Co Ltd Cash Flow-to-Debt Ratio
Nanjing Vazyme Biotech Co Ltd cash flow-to-debt ratio. Nanjing Vazyme Biotech Co Ltd (688105) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥75.30 Million could theoretically repay 0% of its total liabilities (CN¥1.17 Billion) in one year. Check Nanjing Vazyme Biotech Co Ltd (688105) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Nanjing Vazyme Biotech Co Ltd (2017–2025)
Cash flow-to-debt ratio of Nanjing Vazyme Biotech Co Ltd from 2017 to 2025. Historical debt coverage capacity for Nanjing Vazyme Biotech Co Ltd across 9 annual periods. Check 688105 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Nanjing Vazyme Biotech Co Ltd Cash Flow-to-Debt Ratio by Year (2017–2025)
Nanjing Vazyme Biotech Co Ltd cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for Nanjing Vazyme Biotech Co Ltd. For the full cash flow conversion analysis, see 688105 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | CN¥233.16 Million | CN¥1.24 Billion | ▲ +2251.8% |
| 2024 | -0.01x | CN¥-9.68 Million | CN¥1.11 Billion | ▼ -107.6% |
| 2023 | 0.12x | CN¥198.40 Million | CN¥1.72 Billion | ▼ -78.1% |
| 2022 | 0.53x | CN¥735.17 Million | CN¥1.39 Billion | ▼ -58.9% |
| 2021 | 1.29x | CN¥616.80 Million | CN¥479.83 Million | ▼ -55.3% |
| 2020 | 2.88x | CN¥803.55 Million | CN¥279.28 Million | ▲ +2252.8% |
| 2019 | 0.12x | CN¥15.20 Million | CN¥124.31 Million | ▲ +358.9% |
| 2018 | -0.05x | CN¥-4.00 Million | CN¥84.67 Million | ▲ +54.0% |
| 2017 | -0.10x | CN¥-3.86 Million | CN¥37.57 Million | — |